ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer

Symposium
Chairs: T. Berghmans (Brussels, Belgium), P. E. Postmus (Amsterdam, Netherlands)
Aims: There is a substantial and ongoing need for improvements in screening, diagnosis, and treatment of lung cancer, and the proposed talks will provide state-of-the-art updates in these areas by leading researchers. Presenting authors will also be invited to submit scholarly reviews on their topic for The Lancet or The Lancet Respiratory Medicine.
Screening and diagnosis of lung cancer
J. Field (Liverpool, United Kingdom)
Slide presentationMultimedia files
Slide presentationMultimedia files
New and anticipated therapeutic developments in management of non-small-cell lung cancer
M. Reck (Grosshansdorf, Germany)
Slide presentationMultimedia files
Slide presentationMultimedia files
Genetics and tailored treatment of lung cancer
R. Rosell (Badalona (Barcelona), Spain)
Slide presentation
Slide presentation